Senior Director, R&D Communications at Vir Biotechnology

San Francisco, California, United States

Vir Biotechnology Logo
Not SpecifiedCompensation
Senior (5 to 8 years), Expert & Leadership (9+ years)Experience Level
Full TimeJob Type
UnknownVisa
Biopharmaceutical, BiotechnologyIndustries

Requirements

  • Advanced degree in a relevant scientific discipline
  • Minimum of 15 years of experience in communications, with a focus on translating scientific information for diverse audiences
  • Biotech or pharmaceutical industry experience required
  • Passion for storytelling around novel and transformative science and therapeutic candidates
  • Extremely strong verbal, written, and presentation communication skills with a track record of presenting to and coaching senior company leaders
  • Experience driving strategic scientific thought leadership opportunities
  • Demonstrated ability to develop and execute strategic communication plans that align with organizational goals
  • Strong network and relationships with influencers in the scientific and healthcare community

Responsibilities

  • Translate complex scientific concepts into accessible and engaging content for diverse audiences, ensuring clear understanding of our research and development initiatives
  • Develop and manage strategies to establish and enhance scientific thought leadership within the R&D team and the broader organization
  • Identify and capitalize on scientific thought leadership opportunities with the goal of positioning Vir Bio as a leader in the biopharma industry
  • Work with patient advocacy to incorporate patient perspectives into the R&D objectives, ensuring consistent messaging and brand representation
  • Lead and facilitate the dissemination of R&D updates to all stakeholders, utilizing various communication platforms and tactics
  • Gain insights into the rapidly evolving biopharma industry and stay abreast of advancements in research and development
  • Support our CSO and CMO with internal and external engagement preparations
  • Coordinate with leaders across the organization to align R&D communications with overall corporate objectives
  • Identify and facilitate thought leadership opportunities for Vir Bio leaders that highlight both their own and our expertise

Skills

Scientific Communications
Biopharma Knowledge
Thought Leadership
Content Development
Patient Advocacy
Corporate Communications
R&D Strategy
Scientific Writing

Vir Biotechnology

Develops monoclonal antibodies for infectious diseases

About Vir Biotechnology

Vir Biotechnology develops treatments that leverage the immune system to combat infectious diseases. The company uses a proprietary monoclonal antibody platform combined with machine learning to create a database of human antibodies, which aids in developing effective medicines. Their pipeline includes candidates for hepatitis B, hepatitis delta, HIV, and various viruses like influenza and COVID-19. Vir stands out by collaborating with industry leaders and organizations to accelerate scientific advancements, with the goal of transforming lives through innovative therapies.

San Francisco, CaliforniaHeadquarters
2016Year Founded
$640.6MTotal Funding
IPOCompany Stage
AI & Machine Learning, Biotechnology, HealthcareIndustries
501-1,000Employees

Benefits

Comprehensive healthcare coverage
Employer matched 401(k)
Employee stock purchase plan
Childcare assistance
Tuition reimbursement

Risks

Leadership instability due to key executive resignations may disrupt operations.
Job cuts and facility closures indicate potential financial strain.
Struggles to diversify beyond COVID-19 antibody success may impact revenue growth.

Differentiation

Vir Biotechnology uses AI-enhanced capabilities for monoclonal antibody development.
The company focuses on immune system manipulation for targeted therapies.
Vir's pipeline includes a potential functional cure for chronic hepatitis B.

Upsides

Increased interest in AI-driven drug discovery benefits Vir's AI capabilities.
The rise of personalized medicine aligns with Vir's monoclonal antibody focus.
Global pandemic preparedness funding supports Vir's broad-spectrum antiviral therapies.

Land your dream remote job 3x faster with AI